US Patent Issued to Amicus Therapeutics on April 14 for "Treatment of Fabry disease in ERT-naive and ERT-experienced patients" (Pennsylvania Inventor)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,594, issued on April 14, was assigned to Amicus Therapeutics Inc. (Philadelphia).

"Treatment of Fabry disease in ERT-naive and ERT-experienced patients" was invented by Jeff Castelli (New Hope, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are dosing regimens for the treatment of Fabry disease in a patient. Certain methods relate to the treatment of ERT-experienced or ERT-naive Fabry patients. Certain methods comprise administering to the patient about 123 mg free base equivalent of migalastat for improving left ventricular mass and/or improving podocyte globotriaosylceramide."

The patent was filed on May 18, 2023, under Application ...